Participation of calcium ions in the molecular mechanism of cardioprotective action of exogenous phosphocreatine.
The purpose of this study was to find out whether Ca2+ is necessary for the protective effect of phosphocreatine (PCr) on ischemic myocardium. Isolated Langendorff-perfused rat hearts were used in the study. When ischemic arrest was induced in Ca(2+)-free buffer, PCr did not exert a protective effect on ischemic myocardium. PCr improved postischemic contractile recovery of hearts subjected to ischemia in perfusion media containing 0.5 and 1.2 mmol/l Ca2+. Phosphoarginine, a structural analogue of PCr which possesses Ca(2+)-binding property similar to that of PCr did not exert any protective effect on ischemic myocardium. The effects of PCr and Ca2+ on lipid order of sarcolemmal vesicles from canine heart were studied by using ESR spectroscopy. PCr made membrane phospholipids more tightly packed at mildly acidic and neutral pH, but did not at pH 8.5. Although Ca2+ itself did not influence the membrane structure at pH 5.5, it potentiated the effect of PCr on sarcolemmal phospholipids. Thus, the protective effect of PCr on ischemic myocardium is not attributed to its Ca2+ binding properly, but Ca2+ is a necessary component of the mechanism of protective effect of PCr on ischemic myocardium.
Konorev
E A
EA
Institute of Experimental Cardiology, USSR Cardiology Research Center, Moscow.
Medvedeva
N V
NV
Jaliashvili
I V
IV
Lakomkin
V L
VL
Saks
V A
VA
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D004357:Drug Synergism; D004578:Electron Spin Resonance Spectroscopy; D006321:Heart / Q000187:drug effects*; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D010725:Phosphocreatine / Q000494:pharmacology*; D010743:Phospholipids / Q000737:chemistry; D051381:Rats; D011919:Rats, Inbred Strains; D012508:Sarcolemma / Q000737:chemistry / Q000187:drug effects
D010743:Phospholipids; D010725:Phosphocreatine; D002118:Calcium